REQUEST A DEMO
Total
USD $0.00
Search more companies

Unipharma OOD (Bulgaria)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Unipharma OOD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Unipharma OOD is based in Bulgaria, with the head office in Sofia. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was established on June 01, 1998. It currently has a total number of 32 (2023) employees. There was a net sales revenue increase of 6.13% reported in Unipharma OOD’s latest financial highlights for 2022. Over the same period, its total assets grew by 13.46%. The enterprise’s net profit margin increased by 0.97% in 2022.

Headquarters
ul. Han Tervel 7
Sofia; Sofia - city; Postal Code: 1517

Contact Details: Purchase the Unipharma OOD report to view the information.

Website: http://www.unipharma.org

Basic Information
Total Employees:
Purchase the Unipharma OOD report to view the information.
Outstanding Shares:
Purchase the Unipharma OOD report to view the information.
Registered Capital:
Purchase the Unipharma OOD report to view the information.
Incorporation Date:
June 01, 1998
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Unipharma OOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
6.13%
Total operating revenue
5.44%
Operating profit (EBIT)
2634.3%
EBITDA
1547.78%
Net Profit (Loss) for the Period
36.07%
Total assets
13.46%
Total equity
5.85%
Operating Profit Margin (ROS)
96.23%
Net Profit Margin
0.97%
Return on Equity (ROE)
1.23%
Quick Ratio
3.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?